David Roman

Stock Analyst at Goldman Sachs

(4.03)
# 1907
Out of 5,453 analysts
45
Total ratings
Success rate
Average return
22 Stocks
Name Action PT Current % Upside Ratings Updated
CARL Carlsmed
Initiates Coverage On: Buy
19
n/a n/a 1 Aug 18, 2025
OMDA Omada Health
Initiates Coverage On: Buy
29
21.93 32.24% 1 Jul 1, 2025
HQY HealthEquity
Maintains: Neutral
94 104
90.44 14.99% 3 Jun 4, 2025
BBNX Beta Bionics
Initiates Coverage On: Neutral
16
17.73 -9.76% 1 May 30, 2025
PODD Insulet
Initiates Coverage On: Buy
380
331.82 14.52% 1 May 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
80 50
67.41 -25.83% 3 May 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
120 104
107.37 -3.14% 2 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13 10
7.66 30.55% 4 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
94 82
75.21 9.03% 3 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
24 23
18.31 25.61% 2 Apr 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
138 154
132.84 15.93% 2 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
42 24
12 100% 2 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
63 71
73.62 -3.56% 4 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
64 55
55.7 -1.26% 2 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
42
24.52 71.29% 3 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
91 124
169.7 -26.93% 2 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
384 427
394.41 8.26% 2 Jan 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
81 90
81.61 10.28% 3 Dec 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
90
106.03 -15.12% 1 May 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
500
476.5 4.93% 1 May 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
274
199.62 37.26% 1 May 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
83
92.75 -10.51% 1 May 30, 2024